After a promising start to the year, the biotech IPO market picked up steam again late this summer, with notable offerings from companies like Upstream, Septerna and BioAge. But what does this ...

Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...

A new year means a new Fierce Biotech Fundraising Tracker to record all the venture capital being funneled into the industry for 2024. We're bumping up our reporting criteria from last year's ...

South Dakota School of Mines biomechanical engineering class pitches revolutionary research in burn wound care to investors ...

Dec. 5, 2024 — The fungus that causes coffee wilt disease repeatedly took up segments of DNA from a related fungal pathogen, which contributed to successive ... Single Mutation in H5N1 Influenza ...

The Biotech Beach Hotbed includes San Diego, Los Angeles and the surrounding (Torrey Pines, Thousand Oaks) regions of Southern California. SoCal is well-known for its sprawling beaches and ...

In the future, delivering therapeutic drugs exactly where they are needed within the body could be the task of miniature ...

Join biotech commentators Daphne Zohar, Josh Schimmer, and Brad Loncar for a weekly discussion of all things biotech. From emerging trends and investment opportunities to the challenges facing the ...

Both companies are innovative powerhouses with excellent long-term prospects. The biotech industry has lagged the broader market so far in 2024. The SPDR S&P Biotech ETF, an industry benchmark ...

Fidelity Select Biotechnology Portfolio earns an Above Average Process Pillar rating. The most substantial contributor to the rating is its parent firm's excellent long-term risk-adjusted ...

After hours: December 10 at 5:21:10 PM EST Loading Chart for UBX ...